Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$359,672
+$9,111 QoQ
Shares Held
2,295
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,037
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kendall Capital Management holds $22,925,368 across 11 Drug Manufacturers - General names. NVS ranks #11 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
24,818 | $6,245,201 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
69,150 | $3,984,423 | |
| 3 | GSK |
GSK plc
|
50,941 | $2,670,327 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,682 | $2,529,137 | |
| 5 | JNJ |
Johnson & Johnson
|
8,136 | $2,066,299 | |
| 6 | PFE |
Pfizer Inc
|
49,545 | $1,193,043 | |
| 7 | AMGN |
Amgen Inc
|
2,995 | $1,084,549 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,362 | $1,056,455 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $359,672 | 2,295 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $350,561 | 2,295 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $316,411 | 2,295 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $294,310 | 2,295 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $283,768 | 2,345 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $261,420 | 2,345 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $228,191 | 2,345 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $269,721 | 2,345 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $249,648 | 2,345 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $234,183 | 2,421 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $239,298 | 2,370 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $251,594 | 2,470 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $249,247 | 2,470 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $254,840 | 2,770 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $255,467 | 2,816 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $238,747 | 3,141 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $278,357 | 3,293 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $299,929 | 3,418 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $298,972 | 3,418 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $280,260 | 3,427 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $311,858 | 3,418 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $300,718 | 3,518 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $332,204 | 3,518 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $292,011 | 3,358 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $347,875 | 3,983 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $327,161 | 3,968 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||